Jacobson Pharma Announces FY2020 Annual Results
- Written by Reporters
Delivers Solid Performance Amidst Market Challenges
Revenue Increases +6.3%
Maintains Full-Year Dividend Per Share of HK4.5 Cents
HONG KONG, CHINA - Media OutReach - 30 June 2020 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research,...

